Article Text

Download PDFPDF

Inflammatory cells in the airways in COPD
Free
  1. R O’Donnell,
  2. D Breen,
  3. S Wilson,
  4. R Djukanovic
  1. Respiratory Cell and Molecular Biology, Division of Infection, Inflammation and Repair, University of Southampton, Southampton General Hospital, Southampton SO16 6YD, UK
  1. Correspondence to:
    Dr R O’Donnell
    Respiratory Cell and Molecular Biology, Division of Infection, Inflammation and Repair, University of Southampton, Southampton General Hospital, Southampton SO16 6YD, UK;raodonnell{at}eircom.net

Abstract

Airway inflammation is central to the pathogenesis of both airway remodelling and parenchymal destruction in chronic obstructive pulmonary disease (COPD). Neutrophils, macrophages, and CD8+ T lymphocytes have been implicated in a number of studies, but a detailed profile of disease-phenotype specific inflammation has yet to emerge. The heterogeneity of the disease has hindered data interpretation while extrapolation of the results of relatively non-invasive studies to the actual pathology found in the distal lung is difficult. Moreover, prominent studies have had frequently conflicting results. Further investigations are needed to marry the different clinical phenotypes of COPD to their respective inflammatory profiles in the airways and thus improve our understanding of the pathogenesis of the disease as a whole.

  • BAL, bronchoalveolar lavage
  • COPD, chronic obstructive pulmonary disease
  • ECP, eosinophilic cationic protein
  • EGFR, epidermal growth factor receptor
  • FEV1, forced expiratory volume in 1 second
  • IFN-γ, interferon γ
  • IL, interleukin
  • LTB4, leukotriene B4
  • MMP, matrix metalloproteinase
  • MPO, myeloperoxidase
  • NE, neutrophil elastase
  • NK, natural killer
  • TNF-α, tumour necrosis factor α
  • smoking
  • chronic obstructive pulmonary disease
  • airway inflammation

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Funding: none.

  • Competing interests: none.